Inhaled Drug Delivery Summit 2014

The conference programme will include:
Is it the end of the road for MDIs?
Can we improve the way we perform clinical trials.
ASAP.
Parallel Multiple drug/device development.
Globalising the Breezehaler.
Novel Inhalation Therapy.
Bioequivalence guidance.
EMA OIP Guidance.
Emerging Markets: Inhalation products for asthma COPD in China.
Formulation: Inhalation strategies to treat respiratory infections.
Technology: Investigating the output of different inhalers and Nicotine inhalers.

Conference Date: 05-06 Nov 2014
Conference Ref: N11-8114
Fee: £1350 + VAT
Venue: The Rembrandt Hotel, London

Co-chairmen: Dr.Steve Nichols and Dr Ian Smith

KEYNOTE ADDRESS:
Professor Peter Barnes, Professor of Thoracic Medicine and Head of Respiratory Medicine, National Heart and Lung Institute